ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.
, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.
2023, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity, Second Edition, pp. 1803 - 1821, http://dx.doi.org/10.1007/978-3-031-15080-7_138
,2023, 'Amyotrophic lateral sclerosis', in Advances in Magnetic Resonance Technology and Applications, Elsevier, pp. 363 - 385, http://dx.doi.org/10.1016/b978-0-323-91771-1.00016-2
,2023, 'Chemotherapy-Induced Cranial Nerve Damage', in The Cranial Nerves in Neurology, Springer International Publishing, pp. 189 - 193, http://dx.doi.org/10.1007/978-3-031-43081-7_23
,2021, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity, Springer International Publishing, pp. 1 - 19, http://dx.doi.org/10.1007/978-3-030-71519-9_138-1
,2020, 'Transcranial magnetic stimulation in the cortical exploration of dementia', in Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1, pp. 327 - 343, http://dx.doi.org/10.1016/B978-0-12-815854-8.00021-5
,2020, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Dietz V; Ward NS; Kennard C (ed.), Oxford Textbook of Neurorehabilitation, Oxford University Press, pp. 253 - 268, http://dx.doi.org/10.1093/med/9780198824954.003.0019
,2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918
,2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, Routledge, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918-9
,2016, 'Amyotrophic Lateral Sclerosis', in Neurodegenerative Disorders, Springer International Publishing, pp. 145 - 165, http://dx.doi.org/10.1007/978-3-319-23309-3_8
,2015, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Oxford Textbook of Neurorehabilitation, Oxford University Press, USA, pp. 225 - 235
,2014, 'Impulse Conduction: Molecular Perspectives', in Encyclopedia of the Neurological Sciences, pp. 688 - 690, http://dx.doi.org/10.1016/B978-0-12-385157-4.00060-9
,2014, 'Neurotoxicity and ALS: Insights into pathogenesis', in Handbook of Neurotoxicity, pp. 1435 - 1456, http://dx.doi.org/10.1007/978-1-4614-5836-4_138
,, 2013, 'Nerve Conduction Studies', in Encyclopedia of Pain, Springer Berlin Heidelberg, pp. 2024 - 2024, http://dx.doi.org/10.1007/978-3-642-28753-4_101376
2011, 'Spinal Muscular Atrophy', in Encyclopedia of Life Sciences (eLS), John Wiley & Sons, Ltd., Chichester, pp. 1 - 7, http://dx.doi.org/10.1002/9780470015902.a0006011.pub2
,2010, 'Biophysical Properties Underlying Human Nerve Impulse Conduction', in DuBois ML (ed.), Action Potential: Biophysical and Cellular Context, Initiation, Phases and Propagation, Nova Science Publishers, USA, pp. 29 - 63, https://www.novapublishers.com/catalog/product_info.php?cPath=23_483&products_id=14126&osCsid=36c853df640479f435610c963513f08b
,2010, 'Chemotherapy-induced neurotoxicity', in Hayat MA (ed.), Methods of Cancer Diagnosis, Therapy and Prognosis. Volume 7, Springer, USA, pp. 99 - 119, http://www.springer.com/biomed/cancer/book/978-90-481-3185-3
,2007, 'Diagnosis of motor nerone disease', in Kiernan M (ed.), The motor neurone disease handbook, Australasian Medical Publishing Company, Strawberry Hills, N.S.W., pp. 89 - 104
,2007, 'Oxaliplatin-induced neurotoxicity: New pathophysiological insights', in Webster LR (ed.), Neurotoxicity Syndromes, Nova Science Publications, New York, USA, pp. 169 - 181
,2006, 'Assessment of nerve excitability properties in peripheral nerve disease', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 381 - 403
,2006, 'Developments in the assessment of peripheral nerve function', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 927 - 943
,2005, 'Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy: 2-Volume Set with Expert Consult Basic, pp. 113 - 129, http://dx.doi.org/10.1016/B978-0-7216-9491-7.50008-9
,2005, 'Chapter 5 Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy, Elsevier, pp. 113 - 129, http://dx.doi.org/10.1016/b978-0-7216-9491-7.50008-9
,2005, 'Nerve excitability measures: Biophysical basis and use in the investigation of peripheral nerve disease', in Dyck PJ; Thomas PK (ed.), Peripheral Neuropathy, Elsevier Saunders, Unites States, pp. 113 - 129
,2004, 'Threshold electrotonus and the assessment of nerve excitability in amyotrophic lateral sclerosis', in Eisen A (ed.), Handbook of Clinical Neurophysiology. Volume 4: Clinical Neurophysiology of Motor Neurone Disease, Elsevier BV, The Netherlands, pp. 359 - 366
,2003, 'Impulse Conduction', in Encyclopedia of the Neurological Sciences: Volumes 1-4, pp. V2-639-V2-642, http://dx.doi.org/10.1016/B0-12-226870-9/02032-3
,2003, 'Impulse conduction', in Encyclopedia of the Neurological Sciences, Volume 2, Academic Press, San Diego, pp. 639 - 642
,1997, 'Excitability of cutaneous sensory axons in amyotrophic lateralis sclerosis', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 145 - 154
,1997, 'Susceptibility to conduction block: differences in the biophysical properties of cutaneous afferents and motor axons', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 43 - 53
,2024, 'Abnormalities of cortical stimulation strength-duration time constant in amyotrophic lateral sclerosis', Clinical Neurophysiology, 164, pp. 161 - 167, http://dx.doi.org/10.1016/j.clinph.2024.05.014
,2024, 'Distinct neuronal circuits mediate cortical hyperexcitability in amyotrophic lateral sclerosis.', Brain, 147, pp. 2344 - 2356, http://dx.doi.org/10.1093/brain/awae049
,2024, 'Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter', Clinical Neurophysiology, 163, pp. 68 - 89, http://dx.doi.org/10.1016/j.clinph.2024.04.010
,2024, 'Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study', European Journal of Neurology, 31, http://dx.doi.org/10.1111/ene.16281
,2024, 'Stroke is not optional for neurologists.', Pract Neurol, http://dx.doi.org/10.1136/pn-2024-004230
,2024, 'Consensus for experimental design in electromyography (CEDE) project: Checklist for reporting and critically appraising studies using EMG (CEDE-Check)', Journal of Electromyography and Kinesiology, 76, http://dx.doi.org/10.1016/j.jelekin.2024.102874
,2024, 'Identifying optimized assessment of nerve damage during chemotherapy.', Journal of Clinical Oncology, 42, pp. 12016 - 12016, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.12016
,2024, 'Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-024-08484-5
,2024, 'Nanoplastics and Neurodegeneration in ALS', Brain Sciences, 14, http://dx.doi.org/10.3390/brainsci14050471
,2024, 'Upper and lower limb tremor in Charcot–Marie–Tooth neuropathy type 1A and the implications for standing balance', Journal of Neurology, 271, pp. 1776 - 1786, http://dx.doi.org/10.1007/s00415-023-12124-z
,2024, 'Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis', Clinical Neurophysiology, 159, pp. 81 - 95, http://dx.doi.org/10.1016/j.clinph.2024.01.006
,2024, 'The glymphatic system and Amyotrophic lateral sclerosis', Progress in Neurobiology, 234, http://dx.doi.org/10.1016/j.pneurobio.2024.102571
,2024, 'Upper and lower limb tremor in inflammatory neuropathies', Clinical Neurophysiology, 158, pp. 69 - 78, http://dx.doi.org/10.1016/j.clinph.2023.12.005
,2024, 'An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia', Brain Communications, 6, http://dx.doi.org/10.1093/braincomms/fcae123
,2024, 'Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice', Amyloid, 31, pp. 95 - 104, http://dx.doi.org/10.1080/13506129.2024.2313218
,2024, 'Short tandem repeat expansions in LRP12 are absent in cohorts of familial and sporadic amyotrophic lateral sclerosis patients of European ancestry', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, http://dx.doi.org/10.1080/21678421.2024.2348636
,2024, 'Consensus for experimental design in electromyography (CEDE) project: Application of EMG to estimate muscle force', Journal of Electromyography and Kinesiology, pp. 102910 - 102910, http://dx.doi.org/10.1016/j.jelekin.2024.102910
,2023, 'Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01670-2
,2023, 'The importance of patient-centred drug development for amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12944
,2023, 'Utility of split hand index with different motor unit number estimation techniques in ALS', Clinical Neurophysiology, 156, pp. 175 - 182, http://dx.doi.org/10.1016/j.clinph.2023.09.018
,